Published in Physiol Rep on May 02, 2014
Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury. Sci Rep (2015) 0.94
Potential advantages of acute kidney injury management by mesenchymal stem cells. World J Stem Cells (2014) 0.87
Extracellular Vesicles in Renal Pathophysiology. Front Mol Biosci (2017) 0.82
Therapeutic use of human renal progenitor cells for kidney regeneration. Nat Rev Nephrol (2015) 0.81
Trophic Factors from Tissue Stem Cells for Renal Regeneration. Stem Cells Int (2015) 0.78
Human CD133(+) Renal Progenitor Cells Induce Erythropoietin Production and Limit Fibrosis After Acute Tubular Injury. Sci Rep (2016) 0.78
Autologous Cells for Kidney Bioengineering. Curr Transplant Rep (2016) 0.75
Imaging technologies for monitoring the safety, efficacy and mechanisms of action of cell-based regenerative medicine therapies in models of kidney disease. Eur J Pharmacol (2016) 0.75
The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury. Stem Cell Res Ther (2017) 0.75
The exciting "bench to bedside" journey of cell therapies for acute kidney injury and renal transplantation. J Nephrol (2017) 0.75
Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol (2005) 6.71
Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol (2009) 5.01
Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol (2006) 3.95
Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol (2008) 3.80
Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res (2011) 3.73
Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol (2007) 3.60
Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant (2011) 3.49
Isolation of renal progenitor cells from adult human kidney. Am J Pathol (2005) 3.12
Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int (2007) 2.75
Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells (2008) 2.51
Human liver stem cells improve liver injury in a model of fulminant liver failure. Hepatology (2013) 2.24
Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med (2004) 2.16
Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol (2013) 2.12
Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol (2007) 2.02
Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells (2012) 1.78
Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int (2001) 1.69
Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol (2006) 1.59
Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities. Stem Cell Res (2011) 1.45
Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Mol Pharm (2009) 1.38
Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am J Physiol Renal Physiol (2008) 1.36
TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J (2009) 1.33
NFATc1 identifies a population of proximal tubule cell progenitors. J Am Soc Nephrol (2008) 1.28
AKI transition of care: a potential opportunity to detect and prevent CKD. Clin J Am Soc Nephrol (2013) 1.26
Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance. Am J Physiol Renal Physiol (2011) 1.23
Adult human CD133/1(+) kidney cells isolated from papilla integrate into developing kidney tubules. Biochim Biophys Acta (2011) 1.11
Regulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells. Am J Physiol Renal Physiol (2010) 1.10
Erythropoietin and renoprotection. Curr Opin Nephrol Hypertens (2009) 1.07
Circulating IL-6 mediates lung injury via CXCL1 production after acute kidney injury in mice. Am J Physiol Renal Physiol (2012) 1.05
Mouse kidney progenitor cells accelerate renal regeneration and prolong survival after ischemic injury. Stem Cells (2010) 1.02
Labeling human mesenchymal stem cells with fluorescent contrast agents: the biological impact. Mol Imaging Biol (2011) 1.00
Increase of proliferating renal progenitor cells in acute tubular necrosis underlying delayed graft function. Transplantation (2008) 0.98
Mesenchymal stromal cells to promote solid organ transplantation tolerance. Curr Opin Organ Transplant (2013) 0.98
Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives. Stem Cells Transl Med (2013) 0.96
Marrow cell genetic phenotype change induced by human lung cancer cells. Exp Hematol (2011) 0.94
Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats. Transplant Proc (2013) 0.92
Renal CD133(+)/CD73(+) progenitors produce erythropoietin under hypoxia and prolyl hydroxylase inhibition. J Am Soc Nephrol (2013) 0.87
Amelioration of cisplatin-induced acute renal injury by renal progenitor-like cells derived from the adult rat kidney. Cell Transplant (2008) 0.86
Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal homeostasis. Cytokine Growth Factor Rev (2012) 0.83
In vivo tracking of murine adipose tissue-derived multipotent adult stem cells and ex vivo cross-validation. Int J Mol Imaging (2013) 0.81
Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol (2009) 5.01
Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood (2007) 4.73
Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res (2011) 3.50
Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant (2011) 3.49
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol (2012) 3.18
Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One (2010) 3.14
Isolation of renal progenitor cells from adult human kidney. Am J Pathol (2005) 3.12
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00
Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int (2012) 2.47
Isolation and characterization of a stem cell population from adult human liver. Stem Cells (2006) 2.25
Human liver stem cells improve liver injury in a model of fulminant liver failure. Hepatology (2013) 2.24
Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One (2012) 2.23
Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes (2003) 2.17
Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med (2004) 2.16
Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res (2010) 1.96
Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev (2012) 1.91
Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant (2012) 1.88
Identification of a tumor-initiating stem cell population in human renal carcinomas. FASEB J (2008) 1.88
Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J (2003) 1.61
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib. Blood (2007) 1.54
Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol (2008) 1.41
Growth factor delivery from hydrogel particle aggregates to promote tubular regeneration after acute kidney injury. J Control Release (2013) 1.40
CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol (2006) 1.36
Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine (2012) 1.32
Endothelial cell differentiation of human breast tumour stem/progenitor cells. J Cell Mol Med (2009) 1.30
Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes. Diabetes (2009) 1.25
HIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cells. J Biol Chem (2002) 1.24
Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells (2012) 1.23
Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance. Am J Physiol Renal Physiol (2011) 1.23
Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol (2010) 1.22
Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care (2008) 1.22
Isolation and characterization of resident mesenchymal stem cells in human glomeruli. Stem Cells Dev (2009) 1.20
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways. Mol Cancer (2009) 1.20
Contribution of stem cells to kidney repair. Curr Stem Cell Res Ther (2009) 1.20
Macrophage stimulating protein may promote tubular regeneration after acute injury. J Am Soc Nephrol (2008) 1.19
The dynamic stem cell microenvironment is orchestrated by microvesicle-mediated transfer of genetic information. Histol Histopathol (2010) 1.19
Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway. J Am Soc Nephrol (2005) 1.16
The role of microvesicles in tissue repair. Organogenesis (2011) 1.15
Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells. J Biol Chem (2003) 1.15
Contribution of stem cells to kidney repair. Am J Nephrol (2008) 1.15
Improved route for the visualization of stem cells labeled with a Gd-/Eu-chelate as dual (MRI and fluorescence) agent. Magn Reson Med (2004) 1.15
Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets. Cell Transplant (2012) 1.14
Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med (2008) 1.11
Magnetic resonance imaging of gadolinium-labeled pancreatic islets for experimental transplantation. NMR Biomed (2007) 1.08
Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells. Am J Pathol (2002) 1.08
Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice. Neoplasia (2008) 1.07
Tumor exploits alternative strategies to achieve vascularization. FASEB J (2011) 1.07
Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe. Cancer Res (2006) 1.07
Calpain activation and secretion promote glomerular injury in experimental glomerulonephritis: evidence from calpastatin-transgenic mice. J Am Soc Nephrol (2006) 1.06
Differentiation therapy: targeting human renal cancer stem cells with interleukin 15. J Natl Cancer Inst (2011) 1.05
CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J Biol Chem (2003) 1.04
C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood (2007) 1.02
The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes. Am J Pathol (2007) 1.01
Cellular phenotype and extracellular vesicles: basic and clinical considerations. Stem Cells Dev (2014) 1.00
Role of mesenchymal stem cell-derived microvesicles in tissue repair. Pediatr Nephrol (2013) 1.00
HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy. AIDS (2007) 1.00
Isolation and characterization of human breast tumor-derived endothelial cells. Oncol Rep (2006) 0.99
Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. Thromb Haemost (2003) 0.97
Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. Int J Mol Med (2014) 0.97
Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. Kidney Int (2009) 0.97
Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives. Stem Cells Transl Med (2013) 0.96
Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity. Vaccine (2008) 0.96
Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo. Int J Cancer (2011) 0.95
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib. Breast Cancer Res Treat (2010) 0.95
Differentiation of podocyte and proximal tubule-like cells from a mouse kidney-derived stem cell line. Stem Cells Dev (2011) 0.95
Oxytocin induces proliferation and migration in immortalized human dermal microvascular endothelial cells and human breast tumor-derived endothelial cells. Mol Cancer Res (2006) 0.95
Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. Curr Diabetes Rev (2005) 0.94
Persistent infection of human microvascular endothelial cells by coxsackie B viruses induces increased expression of adhesion molecules. J Immunol (2003) 0.94
Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells. J Clin Endocrinol Metab (2012) 0.93
Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone. Am J Physiol Renal Physiol (2009) 0.92
Rationale of mesenchymal stem cell therapy in kidney injury. Am J Kidney Dis (2012) 0.92
Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth. Clin Cancer Res (2003) 0.92
Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population. Exp Cell Res (2009) 0.92
Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS. Int J Mol Med (2002) 0.91
PAX2 expression by HHV-8-infected endothelial cells induced a proangiogenic and proinvasive phenotype. Blood (2007) 0.91
The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells. J Immunol (2003) 0.91